SK3899A3 - Process for the preparation of naphthyridones and intermediates - Google Patents

Process for the preparation of naphthyridones and intermediates Download PDF

Info

Publication number
SK3899A3
SK3899A3 SK38-99A SK3899A SK3899A3 SK 3899 A3 SK3899 A3 SK 3899A3 SK 3899 A SK3899 A SK 3899A SK 3899 A3 SK3899 A3 SK 3899A3
Authority
SK
Slovakia
Prior art keywords
formula
compound
alkyl
trifluoromethyl
amino
Prior art date
Application number
SK38-99A
Other languages
English (en)
Slovak (sk)
Inventor
Kwok-Fung Chiu Charles
Theophilus W Lewin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SK3899A3 publication Critical patent/SK3899A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
SK38-99A 1998-01-16 1999-01-13 Process for the preparation of naphthyridones and intermediates SK3899A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7160198P 1998-01-16 1998-01-16

Publications (1)

Publication Number Publication Date
SK3899A3 true SK3899A3 (en) 2000-03-13

Family

ID=22102373

Family Applications (1)

Application Number Title Priority Date Filing Date
SK38-99A SK3899A3 (en) 1998-01-16 1999-01-13 Process for the preparation of naphthyridones and intermediates

Country Status (39)

Country Link
EP (1) EP0930297B1 (zh)
JP (1) JPH11255745A (zh)
KR (1) KR19990067905A (zh)
CN (1) CN1228422A (zh)
AP (1) AP9901440A0 (zh)
AR (1) AR017228A1 (zh)
AT (1) ATE238281T1 (zh)
AU (1) AU9711598A (zh)
BG (1) BG64094B1 (zh)
BR (1) BR9900066A (zh)
CA (1) CA2258960C (zh)
DE (1) DE69907042T2 (zh)
DK (1) DK0930297T3 (zh)
EA (1) EA199900020A3 (zh)
EG (1) EG21514A (zh)
ES (1) ES2195513T3 (zh)
GT (1) GT199800199A (zh)
HR (1) HRP990013A2 (zh)
HU (1) HUP9900121A3 (zh)
ID (1) ID23612A (zh)
IL (1) IL127945A0 (zh)
IS (1) IS4943A (zh)
MA (1) MA24745A1 (zh)
NO (1) NO990185L (zh)
NZ (1) NZ333769A (zh)
OA (1) OA10955A (zh)
PA (1) PA8464701A1 (zh)
PE (1) PE20000172A1 (zh)
PL (1) PL330859A1 (zh)
PT (1) PT930297E (zh)
SA (1) SA99190971A (zh)
SG (1) SG76584A1 (zh)
SI (1) SI0930297T1 (zh)
SK (1) SK3899A3 (zh)
TN (1) TNSN99005A1 (zh)
TR (1) TR199900070A2 (zh)
TW (1) TW483890B (zh)
YU (1) YU1799A (zh)
ZA (1) ZA99277B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7019142B2 (en) * 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
IE66202B1 (en) * 1989-08-16 1995-12-13 Pfizer Azabicyclo quinolone carboxylic acids
US5256791A (en) * 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
US5475116A (en) * 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
DE19733439A1 (de) * 1997-08-02 1999-02-04 Bayer Ag Neue 6-endo-Amino-3-azabicyclo(3.1.0)hexande, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung von Chinolon- und Naphthyridincarbonsäure-Derviaten mit verbesserten Eigenschaften

Also Published As

Publication number Publication date
AP9901440A0 (en) 1999-03-31
TR199900070A3 (tr) 1999-10-21
JPH11255745A (ja) 1999-09-21
DE69907042D1 (de) 2003-05-28
TW483890B (en) 2002-04-21
AR017228A1 (es) 2001-08-22
KR19990067905A (ko) 1999-08-25
ID23612A (id) 2000-05-04
ES2195513T3 (es) 2003-12-01
TR199900070A2 (xx) 1999-10-21
NO990185L (no) 1999-07-19
HUP9900121A2 (hu) 1999-09-28
PE20000172A1 (es) 2000-03-09
DK0930297T3 (da) 2003-07-21
NZ333769A (en) 2000-03-27
OA10955A (en) 2001-10-31
HU9900121D0 (en) 1999-03-29
CA2258960A1 (en) 1999-07-16
GT199800199A (es) 2000-06-07
ZA99277B (en) 2000-07-17
AU9711598A (en) 1999-08-05
SG76584A1 (en) 2000-11-21
BG103087A (en) 1999-08-31
BG64094B1 (bg) 2003-12-31
PT930297E (pt) 2003-08-29
EP0930297B1 (en) 2003-04-23
IL127945A0 (en) 1999-11-30
CN1228422A (zh) 1999-09-15
EA199900020A2 (ru) 1999-08-26
TNSN99005A1 (fr) 2005-11-10
EG21514A (en) 2001-11-28
SI0930297T1 (en) 2003-08-31
DE69907042T2 (de) 2003-10-16
YU1799A (sh) 2000-03-21
NO990185D0 (no) 1999-01-15
IS4943A (is) 1999-07-17
ATE238281T1 (de) 2003-05-15
BR9900066A (pt) 2000-05-09
SA99190971A (ar) 2005-12-03
EP0930297A1 (en) 1999-07-21
HRP990013A2 (en) 1999-10-31
PA8464701A1 (es) 2000-09-29
CA2258960C (en) 2002-09-03
EA199900020A3 (ru) 1999-12-29
HUP9900121A3 (en) 2000-02-28
PL330859A1 (en) 1999-07-19
MA24745A1 (fr) 1999-10-01

Similar Documents

Publication Publication Date Title
US6184380B1 (en) Process for preparing naphthyridones and intermediates
OKADA et al. Synthesis and Structure-Activity Relationships of 7-(3'-Amino-4'-methoxypyrolidin-1'-yl)-1-cyclopropyl-6, 8-difluoro-1, 4-dihydro-4-oxoquinoline-3-carboxylic Acids
SK3899A3 (en) Process for the preparation of naphthyridones and intermediates
JP2891543B2 (ja) ナフチリドンカルボン酸塩を製造するための方法および中間体
FR2719843A1 (fr) Dérivés de 5,6-dihydro-4h-imidazo [2',1':2,3] imidazo-[4,5,1-ij] quinoléine et de 4,5-dihydroimidazo [1,2-a] pyrrolo-[1,2,3-cd] benzimidazole, leur préparation et leur application en thérapeutique.
US6114531A (en) Process for preparing quinolone and naphthyridone carboxylic acids
WO1988001270A1 (en) Pyridopyrimidinediones
KR100338916B1 (ko) 피롤리디닐 하이드록삼산 화합물의 제조방법
HRP20020471A2 (en) Process for the preparation of 6-methyl-2-(4-methyl-phenyl)-imidazo[1,2-a]pyrimidine-3-(n,n-dimethyl-acetamide) and intermediates
US7019142B2 (en) Process for preparing naphthyridones and intermediates
CZ11999A3 (cs) Způsob výroby naftyridonů a meziprodukty
CZ280931B6 (cs) Opticky aktivní karboxamidové deriváty, farmaceutický prostředek s analgetickým účinkem a prostředek s agonistickým účinkem vzhledem ke k-receptorům
US5929240A (en) Process and intermediates for preparing naphthyridonecarboxylic acid salts
JP3354526B2 (ja) トロバフロキサシン酸塩の製造方法
CZ9902648A3 (cs) Způsob výroby chinolon- a naftyridonkarboxylových kyselin
MXPA99008100A (en) Procedure for preparing aci additional trovafloxacin salts
MXPA99007034A (en) Procedure for preparing acids quinolone and naftiridone carboxili
JPH11255744A (ja) 2,4−二置換および2,3,5−三置換ピロール誘導体およびその製造中間体